Lilly's Alimta gets CHMP rec for new uses; Teva breaks ground on $300M Philadelphia facility;

@FiercePharma: Turns out that fixing Genzyme's manufacturing woes is proving tougher than Sanofi thought. Item | Follow @FiercePharma

> Eli Lilly's cancer drug Alimta won a recommendation from a European regulatory committee for two new indications in lung cancer. Report

> Teva Pharmaceutical Industries broke ground on a new $300 million, three-building distribution center in Philadelphia. More

> Authors of a new study recommend stronger asthma warnings on hormone replacement therapies. Report

> Ipsen has in-licensed Hexvix, a fluorescence agent designed to improve detection and surgery in bladder cancer, from Photocure and GE Healthcare for €19 million up front, plus at least €5 million in milestone payments. Release

> Aiming to expand its consulting services, drug distributor AmerisourceBergen agreed to buy TheraCom from CVS Caremark for $250 million. Article

> European drug distributor Celesio is bowing out of its drug-compliance services joint venture with Medco Health Solutions. Piece

Biotech News

 @FierceBiotech: Novartis seeking approval for NVA237 for smoker's cough after trials showed it helped patients breathe more easily. News | Follow @FierceBiotech

 @RyanMFierce: @FierceMedDev and @arsalanfierce will be tweeting from #AdvaMed2011 this week. Have fun in DC this week! | Follow @RyanMFierce

 @MaureenFierce: Reading: Predicting tox on a chip? DARPA soliciting proposal, could award 5 years of funding. Story | Follow @MaureenFierce

 @FierceMedDev: Mazzo: adding more funding won't address problems at FDA. Fundamental issues won't be addressed by throwing money at problem. #AdvaMed2011 | Follow @FierceMedDev

> Cancer drug shortages threaten to derail hundreds of clinical trials. News

> Biotech accused deposed CEO of doctoring resume, stock scheme. Story

Pharma Manufacturing News

> Bayer, union at odds over outsourcing promised jobs. Report

> Barcode is India's choice of track/trace weapon. Story

> Taiwan take-down nets fakes-makers, retailers. Report

> Drug in regulatory limbo a headache for Shire, FDA. Piece

> Merck, MedImmune deal space. More

Biotech Research News

> Fred Hutch sequencing project unveils key triggers for prostate cancer. Item

> NIH buddies with Afraxis to escort Fragile X program through "valley of death". Article

> Johns Hopkins researcher designs self-destruct switch for cancer cells. Report

> Sequencing leaders want industry standards to govern decoded DNA. More

And Finally... Women who regularly drink caffeinated coffee have a 20% lower risk of depression. Report

Suggested Articles

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…